ANTX
ANTX
US0373261058
AN2 Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
166.04M EUR
175.73M EUR
123.07M EUR
31.25M EUR
Enterprise Value
98.22M EUR
131.42M EUR
69.58M EUR
11.31M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-5.5x
--
--
--
Price to Sales
--
--
--
--
Price to Book
2.1x
2.31x
1.51x
0.59x
EV/Revenue
--
--
--
--
EV/EBITDA
--
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-10.85%
-17.46%
-25.42%
-61.47%
ende